Internal Medicine, Endocrinology, Diabetes, & Metabolism · Jacksonville, FL
NPI
1881700698
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
8837 Goodbys Executive Dr
Jacksonville, FL, 32217
Phone (904) 990-0555
Groups this clinician bills Medicare through
Medicare paid, 2024
$474K
18,440 services
Medicare patients, 2024
853
Average age 73
Drug cost, 2024
$4.2M
12,546 prescriptions
Company payments, 2025
$38K
From 42 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wasim E Deeb was code J0897 (injection, denosumab, 1 mg), 13,500 times for 124 patients. In total Wasim E Deeb billed 18,440 services in 22 codes, and Medicare paid $474K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-08-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 13,500 | 124 | $20.52 | $277K |
| 99214 Office E&M - Established | Office | 1,426 | 710 | $86.34 | $123K |
| 96372 Injection Administration | Office | 723 | 338 | $10.40 | $7,516 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 466 | 250 | $0.90 | $420 |
| 99215 Office E&M - Established | Office | 260 | 145 | $134.31 | $35K |
| 83036 Blood Count | Office | 246 | 180 | $9.42 | $2,316 |
| 82962 Clinical Chemistry | Office | 198 | 152 | $3.21 | $636 |
| 95251 Test - Miscellaneous | Office | 189 | 100 | $25.83 | $4,881 |
| 99204 Office E&M - New | Office | 104 | 104 | $108.41 | $11K |
| 99205 Office E&M - New | Office | 49 | 49 | $152.99 | $7,497 |
| 95250 Test - Miscellaneous | Office | 17 | 15 | $104.84 | $1,782 |
| 10005 Other Organ Systems | Office | 14 | 14 | $89.23 | $1,249 |
| 76942 Ultrasound - Nonspecific | Office | 11 | 11 | $37.36 | $411 |
By year: 2022 $346K for 19,672 services; 2023 $401K for 16,514 services; 2024 $474K for 18,440 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 246 | 180 | $9.42 | $2,316 |
| 82962 Clinical Chemistry | 198 | 152 | $3.21 | $636 |
Medicare prescription drug claims, 2024
In 2024, the drug Wasim E Deeb prescribed most often to Medicare patients was Pioglitazone Hcl, with 1,295 prescriptions and refills. In total Wasim E Deeb wrote 12,546 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pioglitazone Hcl Generic | 1,295 | 3,271 | 418 | $15K |
| Rosuvastatin Calcium Generic | 701 | 1,802 | 234 | $8,904 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 688 | 1,022 | 179 | $454K |
| Levothyroxine Sodium Generic | 674 | 1,789 | 247 | $5,623 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 641 | 1,653 | 232 | $7,350 |
| Ozempic Semaglutide | 620 | 997 | 175 | $948K |
| Liothyronine Sodium Generic | 533 | 1,448 | 197 | $16K |
| Unithroid Levothyroxine Sodium | 471 | 1,256 | 184 | $19K |
| Jardiance Empagliflozin | 443 | 801 | 142 | $445K |
| Atorvastatin Calcium Generic | 338 | 973 | 128 | $2,662 |
| Farxiga Dapagliflozin Propanediol | 322 | 531 | 95 | $295K |
| Bupropion Xl Bupropion Hcl | 296 | 687 | 93 | $7,685 |
| Kerendia Finerenone | 259 | 365 | 62 | $232K |
| Lisinopril Generic | 221 | 586 | 80 | $1,430 |
| Repaglinide Generic | 207 | 521 | 93 | $6,855 |
Brand drugs: 5,146 claims; generic drugs: 7,103 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wasim E Deeb $38K ($38K in general payments such as food, travel and fees) from 42 companies. The largest payer was Novo Nordisk Inc with $26K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 41 | $26K |
| Amgen Inc. AMGN | 29 | $5,445 |
| CeQur Corporation | 2 | $2,596 |
| Insulet Corporation PODD | 18 | $401 |
| Abbott Laboratories ABT | 12 | $358 |
| Madrigal Pharmaceuticals MDGL | 10 | $269 |
| Dexcom, Inc. DXCM | 10 | $247 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $199 |
| IBSA Pharma Inc. | 14 | $174 |
| Radius Health, Inc. | 6 | $156 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.